KalVista Pharmaceuticals, Inc. - COM (KALV)

Historical Holders from Q4 2016 to Q1 2025

Symbol
KALV on Nasdaq
CUSIP
483497103
Type / Class
Equity / COM
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
55.2M
Holdings value
$467M
% of all portfolios
0.003%
Grand Portfolio weight change
+0%
Number of holders
129
Number of buys
69
Number of sells
-46
Average Value change %
+0%
Average buys %
+0.001%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of KalVista Pharmaceuticals, Inc. - COM (KALV)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 167K $1.93M +$339K $11.54 8
2024 Q4 55.2M $467M +$30.4M $8.47 129
2024 Q3 48.4M $561M +$550K $11.58 120
2024 Q2 48.2M $568M +$14.3M $11.78 118
2024 Q1 47M $557M +$118M $11.86 127
2023 Q4 37M $453M +$2.82M $12.25 92
2023 Q3 36.3M $349M +$17.9M $9.63 101
2023 Q2 34.5M $310M +$8.86M $9.00 93
2023 Q1 33.7M $265M -$7.3M $7.86 87
2022 Q4 33.8M $229M +$23.5M $6.76 88
2022 Q3 25.6M $371M +$16.6M $14.51 85
2022 Q2 24.2M $238M -$18.1M $9.84 83
2022 Q1 23.9M $352M +$6.71M $14.74 79
2021 Q4 23.8M $315M -$24.2M $13.23 93
2021 Q3 23.4M $408M -$21.5M $17.45 101
2021 Q2 24.2M $581M +$10.8M $23.96 108
2021 Q1 23.5M $604M +$242M $25.69 114
2020 Q4 14.6M $278M +$4.58M $18.99 78
2020 Q3 15.6M $197M +$2.83M $12.59 60
2020 Q2 16M $194M +$9.42M $12.10 72
2020 Q1 15.6M $120M +$17.3M $7.65 67
2019 Q4 13.7M $244M +$13.4M $17.81 71
2019 Q3 13.2M $153M -$34M $11.60 74
2019 Q2 14.8M $327M +$6.26M $22.15 73
2019 Q1 13.9M $398M +$23.8M $28.62 67
2018 Q4 13M $256M +$10.7M $19.75 55
2018 Q3 12.3M $271M +$111M $22.11 46
2018 Q2 6.32M $51.3M -$1.58M $8.12 24
2018 Q1 6.5M $61.6M +$134K $9.48 22
2017 Q4 6.48M $63.2M -$3M $9.75 22
2017 Q3 7.72M $52.2M +$2.31M $6.73 15
2017 Q2 7.37M $54.1M -$1.77M $7.36 16
2017 Q1 7.59M $59.2M +$2.02M $7.81 17
2016 Q4 7.33M $51.5M +$47M $7.07 18